BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34331823)

  • 1. Evaluation of four pre-operative models for prediction of biochemical recurrence after radical prostatectomy in localised prostate cancer.
    Kutluhan MA; Ünal S; Özsoy E; Şahin A; Özayar A; Okulu E; Kayıgil Ö
    Int J Clin Pract; 2021 Oct; 75(10):e14682. PubMed ID: 34331823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of biochemical recurrence-free survival after radical prostatectomy by cancer of the prostate risk assessment post-surgical (CAPRA-S) score.
    Aktas BK; Ozden C; Bulut S; Tagci S; Erbay G; Gokkaya CS; Baykam MM; Memis A
    Asian Pac J Cancer Prev; 2015; 16(6):2527-30. PubMed ID: 25824791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Prostate Cancer Risk Index (PRIX): a simple scoring system to predict risk of biochemical relapse after radical prostatectomy for prostate cancer.
    Yoshida T; Nakayama M; Matsuzaki K; Kobayashi Y; Takeda K; Arai Y; Kakimoto K; Nishimura K
    Jpn J Clin Oncol; 2011 Nov; 41(11):1271-6. PubMed ID: 21971422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese patients receiving radical prostatectomy.
    Ishizaki F; Hoque MA; Nishiyama T; Kawasaki T; Kasahara T; Hara N; Takizawa I; Saito T; Kitamura Y; Akazawa K; Takahashi K
    Jpn J Clin Oncol; 2011 Nov; 41(11):1259-64. PubMed ID: 21940731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
    Merriman KM; Harmon SA; Belue MJ; Yilmaz EC; Blake Z; Lay NS; Phelps TE; Merino MJ; Parnes HL; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
    AJR Am J Roentgenol; 2023 Dec; 221(6):773-787. PubMed ID: 37404084
    [No Abstract]   [Full Text] [Related]  

  • 6. PSA density does not improve predictive accuracy of the UCSF-CAPRA score.
    Parker R; Bell A; Chang K; Greenberg S; Washington SL; Cowan JE; Carroll PR; Cooperberg MR
    Prostate; 2023 Jul; 83(10):922-928. PubMed ID: 37078628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy.
    Pagano MJ; Whalen MJ; Paulucci DJ; Reddy BN; Matulay JT; Rothberg M; Scarberry K; Patel T; Shapiro EY; RoyChoudhury A; McKiernan J; Benson MC; Badani KK
    Prostate; 2016 Feb; 76(2):226-34. PubMed ID: 26481325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the Biochemical Recurrence risk between Radical Prostatectomy and Brachytherapy in the treatment of low- and intermediate-risk prostate cancer].
    Martínez PF; Belisle DF; Cristallo C; Tobía I; Damia O; Villamil W; Giudice CR
    Arch Esp Urol; 2015 Oct; 68(8):655-60. PubMed ID: 26437328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.
    Boehm K; Larcher A; Beyer B; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Heinzer H; Graefen M; Budäus L
    Eur Urol; 2016 Jun; 69(6):1038-43. PubMed ID: 26272236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.
    Walz J; Joniau S; Chun FK; Isbarn H; Jeldres C; Yossepowitch O; Chao-Yu H; Klein EA; Scardino PT; Reuther A; Poppel HV; Graefen M; Huland H; Karakiewicz PI
    BJU Int; 2011 Mar; 107(5):765-770. PubMed ID: 20875089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Biochemical Recurrence After Radical Prostatectomy Based on Preoperative
    Qiu X; Chen M; Yin H; Zhang Q; Li H; Guo S; Fu Y; Zang S; Ai S; Wang F; Guo H
    Front Oncol; 2021; 11():745530. PubMed ID: 34660310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer.
    Kang M; Jeong CW; Choi WS; Park YH; Cho SY; Lee S; Lee SB; Ku JH; Hong SK; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE;
    PLoS One; 2014; 9(6):e100053. PubMed ID: 24936784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.
    Mazzone E; Gandaglia G; Ploussard G; Marra G; Valerio M; Campi R; Mari A; Minervini A; Serni S; Moschini M; Marquis A; Beauval JB; van den Bergh R; Rahota RG; Soeterik T; Roumiguiè M; Afferi L; Zhuang J; Guo H; Mattei A; Gontero P; Cucchiara V; Stabile A; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2022 Feb; 81(2):193-203. PubMed ID: 34399996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-based prognostic nomogram for prostate cancer after radical prostatectomy.
    Zhang YD; Wu CJ; Bao ML; Li H; Wang XN; Liu XS; Shi HB
    J Magn Reson Imaging; 2017 Feb; 45(2):586-596. PubMed ID: 27654116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.
    Narita S; Mitsuzuka K; Tsuchiya N; Koie T; Kawamura S; Ohyama C; Tochigi T; Yamaguchi T; Arai Y; Habuchi T;
    Int J Urol; 2015 Nov; 22(11):1029-35. PubMed ID: 26290306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
    Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
    Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nomogram provides improved accuracy for predicting biochemical recurrence after radical prostatectomy.
    Xia HZ; Bi H; Yan Y; Yang B; Ma RZ; He W; Zhu XH; Zhang ZY; Zhang YT; Ma LL; Hou XF; Wirth GJ; Lu J
    Chin Med J (Engl); 2021 Jun; 134(13):1576-1583. PubMed ID: 34133352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer.
    Beauval JB; Roumiguié M; Filleron T; Benoit T; de la Taille A; Malavaud B; Salomon L; Soulié M; Ploussard G
    BMC Urol; 2016 Jun; 16(1):26. PubMed ID: 27267988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Biochemical Recurrence and Correlation with Various Parameters After Robotic-Assisted Radical Prostatectomy: a Single Center Experience.
    Singh M; Kathuria S; Jain S; Rasool S; Tyagi V; Gupta M; Pahwa M; Pandey H; Sharma A
    Indian J Surg Oncol; 2022 Sep; 13(3):661-667. PubMed ID: 36187532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.